ArticleJournal of pharmaceutical analysis2026

Luteolin attenuates RA-associated chronic pain by targeting the LDHA/H3K9la/NFATC2 axis to suppress Th17 cell differentiation and central infiltration.

Yuepeng Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.